EX-99.11 12 december202018-pdmrxexhibi.htm EXHIBIT 99.11 Exhibit


EXHIBIT 99.11

Press Release
shirelogobluergba80.jpg
www.shire.com
 




Director/PDMR Shareholding

20 December, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG)

Notification of transactions by persons discharging managerial responsibilities

1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)
Name
Susan Kilsby
2.
Reason for the notification
a)
Position / status
Chairman - PDMR
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)
Name
Shire plc
b)
LEI
54930005LQRLI2UXRQ59
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Shire plc American Depositary Shares (“ADSs”)
Identification code
ISIN: US82481R1068
b)
Nature of the transaction
Acquisition of ADSs, being the part of Ms. Kilsby’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$168.0470
164
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
December 19, 2018
f)
Place of the transaction
XNAS / XBOS / ARCX





1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)
Name
Olivier Bohuon
2.
Reason for the notification
a)
Position / status
Senior Independent Director - PDMR
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)
Name
Shire plc
b)
LEI
54930005LQRLI2UXRQ59
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
Identification code
ISIN: JE00B2QKY057
b)
Nature of the transaction
Acquisition of Ordinary Shares, being the part of Mr. Bohuon’s total fees that are paid in Ordinary Shares for the period of service from October 1 to December 31, 2018.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£44.31
140
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
December 19, 2018
f)
Place of the transaction
LSE (TRQX)

1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)
Name
Ian Clark
2.
Reason for the notification
a)
Position / status
Non-Executive Director - PDMR
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)
Name
Shire plc
b)
LEI
54930005LQRLI2UXRQ59
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Shire plc American Depositary Shares (“ADSs”)
Identification code
ISIN: US82481R1068
b)
Nature of the transaction
Acquisition of ADSs, being the part of Mr. Clark’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$168.0470
44
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
December 19, 2018
f)
Place of the transaction
XNAS / XBOS / ARCX





1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)
Name
Gail Fosler
2.
Reason for the notification
a)
Position / status
Non-Executive Director - PDMR
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)
Name
Shire plc
b)
LEI
54930005LQRLI2UXRQ59
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Shire plc American Depositary Shares (“ADSs”)
Identification code
ISIN: US82481R1068
b)
Nature of the transaction
Acquisition of ADSs, being the part of Ms. Fosler’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$168.0470
47
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
December 19, 2018
f)
Place of the transaction
XNAS / XBOS / ARCX

1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)
Name
Steven Gillis
2.
Reason for the notification
a)
Position / status
Non-Executive Director - PDMR
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)
Name
Shire plc
b)
LEI
54930005LQRLI2UXRQ59
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Shire plc American Depositary Shares (“ADSs”)
Identification code
ISIN: US82481R1068
b)
Nature of the transaction
Acquisition of ADSs, being the part of Dr. Gillis’ total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$168.0470
49
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
December 19, 2018
f)
Place of the transaction
XNAS / XBOS / ARCX





1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)
Name
David Ginsburg
2.
Reason for the notification
a)
Position / status
Non-Executive Director - PDMR
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)
Name
Shire plc
b)
LEI
54930005LQRLI2UXRQ59
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Shire plc American Depositary Shares (“ADSs”)
Identification code
ISIN: US82481R1068
b)
Nature of the transaction
Acquisition of ADSs, being the part of Dr. Ginsburg’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$168.0470
44
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
December 19, 2018
f)
Place of the transaction
XNAS / XBOS / ARCX

1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)
Name
Sara Mathew
2.
Reason for the notification
a)
Position / status
Non-Executive Director - PDMR
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)
Name
Shire plc
b)
LEI
54930005LQRLI2UXRQ59
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Shire plc American Depositary Shares (“ADSs”)
Identification code
ISIN: US82481R1068
b)
Nature of the transaction
Acquisition of ADSs, being the part of Ms. Mathew’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$168.0470
46
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
December 19, 2018
f)
Place of the transaction
XNAS / XBOS / ARCX





1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)
Name
Albert Stroucken
2.
Reason for the notification
a)
Position / status
Non-Executive Director - PDMR
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)
Name
Shire plc
b)
LEI
54930005LQRLI2UXRQ59
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Shire plc American Depositary Shares (“ADSs”)
Identification code
ISIN: US82481R1068
b)
Nature of the transaction
Acquisition of ADSs, being the part of Mr. Stroucken’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$168.0470
63
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
December 19, 2018
f)
Place of the transaction
XNAS / XBOS / ARCX

Sarah Rixon
Senior Company Secretarial Assistant
For further information please contact:

Investor Relations
 
 
Christoph Brackmann
christoph.brackmann@shire.com
+41 41 288 41 29
Sun Kim
sun.kim@shire.com
+1 617 588 8175
Scott Burrows
scott.burrows@shire.com
+41 41 288 4195
 
 
 
Media
 
 
Katie Joyce
kjoyce@shire.com
+1 781 482 2779

NOTES TO EDITORS

About Shire
 
Shire is the global biotechnology leader serving patients with rare diseases and specialized conditions. We seek to push boundaries through discovering and delivering new possibilities for patient communities who often have few or no other champions. Relentlessly on the edge of what’s next, we are serial innovators with a diverse pipeline offering fresh thinking and new hope. Serving patients and partnering with healthcare communities in over 100 countries, we strive to be part of the entire patient journey to enable earlier diagnosis, raise standards of care, accelerate access to treatment, and support patients. Our diverse portfolio of therapeutic areas includes Immunology, Hematology, Genetic Diseases, Neuroscience, Internal Medicine, and Ophthalmics.

Championing patients is our call to action - it brings the opportunity - and responsibility - to change people’s lives.
 
www.shire.com